Cargando…

Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats

Heart failure with preserved ejection fraction (HFpEF) is a complex cardiovascular insufficiency syndrome presenting with an ejection fraction (EF) of greater than 50% along with different proinflammatory and metabolic co-morbidities. Despite previous work provided key insights into our understandin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhazykbayeva, Saltanat, Hassoun, Roua, Herwig, Melissa, Budde, Heidi, Kovács, Árpád, Mannherz, Hans Georg, El-Battrawy, Ibrahim, Tóth, Attila, Schmidt, Wolfgang E., Mügge, Andreas, Hamdani, Nazha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285478/ https://www.ncbi.nlm.nih.gov/pubmed/37363100 http://dx.doi.org/10.3389/fcvm.2023.1157398

Ejemplares similares

Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
por: Budde, Heidi, et al.
Publicado: (2022)

Cardiomyocyte Dysfunction in Inherited Cardiomyopathies
por: Hassoun, Roua, et al.
Publicado: (2021)

Interventricular Differences of Signaling Pathways-Mediated Regulation of Cardiomyocyte Function in Response to High Oxidative Stress in the Post-Ischemic Failing Rat Heart
por: Kovács, Árpád, et al.
Publicado: (2021)

The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts
por: Budde, Heidi, et al.
Publicado: (2021)

Ca2+/calmodulin‐dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model
por: Gömöri, Kamilla, et al.
Publicado: (2022)

The molecular mechanisms associated with the physiological responses to inflammation and oxidative stress in cardiovascular diseases
por: Zhazykbayeva, Saltanat, et al.
Publicado: (2020)

SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress
por: Tangos, Melina, et al.
Publicado: (2022)

Integration of Cardiac Actin Mutants Causing Hypertrophic (p.A295S) and Dilated Cardiomyopathy (p.R312H and p.E361G) into Cellular Structures
por: Erdmann, Constanze, et al.
Publicado: (2021)

Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced Hypertrophy
por: Gömöri, Kamilla, et al.
Publicado: (2022)

Functional Characterization of Cardiac Actin Mutants Causing Hypertrophic (p.A295S) and Dilated Cardiomyopathy (p.R312H and p.E361G)
por: Hassoun, Roua, et al.
Publicado: (2022)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
por: Chowdhury, Shahryar M., et al.
Publicado: (2022)

Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Afshar, Majid, et al.
Publicado: (2012)

Impact of Updated Guidelines on Diastolic Dysfunction in Patients with Preserved Ejection Fraction
por: Yoon, Hyun Ju
Publicado: (2021)

Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
por: Wenzel, Jan-Per, et al.
Publicado: (2021)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
por: Teuber, James P., et al.
Publicado: (2022)

Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator
por: Kolijn, Detmar, et al.
Publicado: (2020)

Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction
por: Sebastião, Maria J., et al.
Publicado: (2022)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
por: Scheffer, Mariëlle, et al.
Publicado: (2020)

Reviving the origins: acoustic biomarkers of heart failure with preserved ejection fraction
por: Tokodi, Márton, et al.
Publicado: (2022)

De Novo Missense Mutations in TNNC1 and TNNI3 Causing Severe Infantile Cardiomyopathy Affect Myofilament Structure and Function and Are Modulated by Troponin Targeting Agents
por: Hassoun, Roua, et al.
Publicado: (2021)

Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction
por: Park, Jin Joo, et al.
Publicado: (2022)

A Case of Postpartum Pulmonary Edema With Preserved Ejection Fraction and Diastolic Capacity
por: Tanabe, Shohei, et al.
Publicado: (2022)

Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?
por: Kovács, Á., et al.
Publicado: (2016)

Epigenetic remodeling in heart failure with preserved ejection fraction
por: Ambrosini, Samuele, et al.
Publicado: (2022)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction
por: Fuchida, Aya, et al.
Publicado: (2021)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

Diet modification reverses diastolic dysfunction in rats with heart failure and preserved ejection fraction
por: Kim, Myung Yoon, et al.
Publicado: (2023)

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2023)

The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation
por: El-Battrawy, Ibrahim, et al.
Publicado: (2023)

Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach
por: Cimiotti, Diana, et al.
Publicado: (2021)

Diastolic dysfunction in patients with preserved ejection fraction: identification by velocity encoded magnetic resonance imaging
por: Radunski, Ulf K, et al.
Publicado: (2011)

Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction
por: Zheng, Huan, et al.
Publicado: (2014)

The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction. A Doppler-Echocardiographic study
por: Cacciapuoti, Federico, et al.
Publicado: (2017)

Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction
por: Coculescu, Bogdan Ioan, et al.
Publicado: (2018)

Left Atrial Size and Heart Failure Hospitalization in Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Issa, Omar, et al.
Publicado: (2017)

Heart Failure With Preserved Ejection Fraction　― Time for a Paradigm Shift Beyond Diastolic Function ―
por: Oki, Takashi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9bla9k72k19vvjh9o3v0mu65gc